Results 291 to 300 of about 40,229,784 (363)

Correction: UHRF1-mediated epigenetic reprogramming regulates glycolysis to promote progression of B-cell acute lymphoblastic leukemia. [PDF]

open access: yesCell Death Dis
Huang Y   +12 more
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Retraction Note: Targeting transforming growth factor beta (TGF-β) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer. [PDF]

open access: yesSci Rep
Jamialahmadi H   +17 more
europepmc   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Correction: Alkaline electrocatalytic water oxidation by Fe-Ni nanostructures on porous turbostratic carbon with tailorable metal-metal active sites. [PDF]

open access: yesChem Sci
Saha D   +12 more
europepmc   +1 more source

Retraction Note: Diabetes mellitus and risk of incident dementia in APOE ɛ4 carriers: an updated meta-analysis. [PDF]

open access: yesBMC Neurosci
Rashtchian A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy